Skip to main content
Equibles

Lynn Haichong

Analyst

Goldman Sachs

Equibles does not estimate personal net worth.

About Lynn Haichong

Lynn Haichong is recorded as Analyst at Goldman Sachs. Lynn Haichong has spoken on 1 earnings call across 1 company, most recently for Zai Lab Ltd on February 26, 2026. The companies whose calls Lynn Haichong spoke on are classified in the Healthcare sector.

Lynn Haichong on recent calls

“The first one is regarding the Phase III trial for the second-line small-cell lung cancer understood that the current clinical protocol does not take telotomib as a control arm, but it was allowed to be available both as a prior treatment option and the post-progression treatment options.”
Analyst — Goldman Sachs, Q4 Earnings conference call (announced in 8-K) ·

Affiliation history

  • Goldman Sachs

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity